60548-09-6 Usage
General Description
1-(2-Furanylcarbonyl)piperazine hydrochloride is a chemical compound that consists of a piperazine ring with a furfurylcarbonyl group attached to it. It is commonly used as a precursor for the synthesis of various pharmaceutical compounds and research chemicals. The hydrochloride salt form of this compound makes it more stable and easier to handle in laboratory settings. 1-(2-Furanylcarbonyl)piperazine hydrochloride has been investigated for its potential use in the treatment of central nervous system disorders and has shown promise as a potential therapeutic agent. It is important to handle this chemical with care and follow proper safety protocols when working with it in a laboratory setting.
Check Digit Verification of cas no
The CAS Registry Mumber 60548-09-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,5,4 and 8 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 60548-09:
(7*6)+(6*0)+(5*5)+(4*4)+(3*8)+(2*0)+(1*9)=116
116 % 10 = 6
So 60548-09-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O2.ClH/c12-9(8-2-1-7-13-8)11-5-3-10-4-6-11;/h1-2,7,10H,3-6H2;1H
60548-09-6Relevant articles and documents
2-,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use
-
, (2008/06/13)
The present invention provides substituted dibenzoxazepine and dibenzthiazepine compounds of Formula I: STR1 which are useful as analgesic agents for the treatment of pain, and for prostaglandin-E2 mediated diseases, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal, and a method for treating prostaglandin-E2 mediated diseases in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.